Mucormicosis invasora en pacientes con COVID-19: reporte de 2 casos

Simple item page
dc.coverageDOI: 10.4067/S0034-98872023000100125
dc.creatorCamhi, Dana
dc.creatorIgnacia López, María
dc.creatorWiener, Alan
dc.creatorHeinriksen, Karin
dc.creatorPérez, Ignacio
dc.creatorVerdugo, Fernando
dc.creatorRosas, Reinaldo
dc.creatorFarías, Pamela
dc.date2023
dc.date.accessioned2025-11-18T19:56:35Z
dc.date.available2025-11-18T19:56:35Z
dc.description<p>COVID-19 disease is associated with a significant number of opportunistic infections, including invasive fungal infections such as mucormycosis. The prevalence of the latter is rare, estimated to be between 0.005 and 1.7 per million inhabitants. Risk factors include hematological diseases, Diabetes Mellitus with poor metabolic control, solid organ transplantation, neutropenia, and prolonged administration of systemic corticosteroids. We report two males aged 60 and 75 years with pulmonary and tracheobronchial invasive mucormycosis, respectively. Both patients had a deficient metabolic control of their diabetes as a predisposing risk factor added to severe COVID-19 infection. High suspicion and early diagnosis are essential for prompt treatment, especially considering the associated high morbidity and mortality of this fungal infection.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/594af776-2f1a-45ac-9ad7-90d88035c17d
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/59881
dc.languagespa
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.151 (2023) nr.1 p.125-128
dc.subjectCOVID-19
dc.subjectDiabetes Mellitus
dc.subjectMucormycosis
dc.subjectOpportunistic Infections
dc.subjectSDG 3 - Good Health and Well-being
dc.titleMucormicosis invasora en pacientes con COVID-19: reporte de 2 casosspa
dc.titleInvasive mucormycosis during COVID-19 infection. Report of two caseseng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
PURE